Mostrar el registro sencillo del ítem
Synthesis, docking and pharmacological evaluation of novel homo- and hetero-bis 3-piperazinylpropylindole derivatives at SERT and 5-HT1A receptor
dc.contributor.author | Pessoa-Mahana H. | |
dc.contributor.author | González-Lira C. | |
dc.contributor.author | Fierro A. | |
dc.contributor.author | Zapata-Torres G. | |
dc.contributor.author | Pessoa-Mahana C.D. | |
dc.contributor.author | Ortiz-Severin J. | |
dc.contributor.author | Iturriaga-Vásquez P. | |
dc.contributor.author | Reyes-Parada M. | |
dc.contributor.author | Silva-Matus P. | |
dc.contributor.author | Saitz-Barría C. | |
dc.contributor.author | Araya-Maturana R. | |
dc.date.accessioned | 2020-09-02T22:25:48Z | |
dc.date.available | 2020-09-02T22:25:48Z | |
dc.date.issued | 2013 | |
dc.identifier | 10.1016/j.bmc.2013.10.036 | |
dc.identifier.citation | 21, 24, 7604-7611 | |
dc.identifier.issn | 09680896 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12728/5786 | |
dc.description | A series of 3-(3-(4-(3-(1H-indol-3-yl)propyl)piperazin-1-yl)propyl)-1H- indole derivatives (3a-d and 5a-f) as homo- and hetero-bis-ligands, were synthesized and evaluated for in vitro affinity at the serotonin transporter (SERT) and the 5-HT1A receptor. Compounds 5b and 5f showed nanomolar affinities for both targets. The experimental data were rationalized according to results obtained from docking experiments. These findings are in agreement with our proposal that bis-indole derivatives can bind both targets, and might serve as leads in the quest of ligands endowed with a dual mechanism of action. © 2013 Elsevier Ltd. All rights reserved. | |
dc.language.iso | en | |
dc.subject | 5-Hydroxytryptamine 1A receptor | |
dc.subject | Bivalent ligands | |
dc.subject | Docking | |
dc.subject | Piperazinylpropylindole derivatives | |
dc.subject | Serotonin transporter | |
dc.subject | 1,4 bis[3 (1h 3 indolyl)propyl]piperazine | |
dc.subject | 1,4 bis[3 (5 bromo 1h 3 indolyl)propyl]piperazine | |
dc.subject | 1,4 bis[3 (5 fluoro 1h 3 indolyl]propyl)piperazine | |
dc.subject | 1,4 bis[3 (5 methoxy 1h 3 indolyl]propyl)piperazine | |
dc.subject | 3 [3 [4 [3 (1h 3 indolyl)propyl] 1 piperazinyl]propyl] 5 bromo 1h indol | |
dc.subject | 3 [3 [4 [3 (1h 3 indolyl)propyl] 1 piperazinyl]propyl] 5 fluoro 1h indol | |
dc.subject | 3 [3 [4 [3 (1h 3 indolyl)propyl] 1 piperazinyl]propyl] 5 methoxy 1h indol | |
dc.subject | 3 [3 [4 [3 (1h indol 3 yl)propyl]piperazin 1 yl]propyl] 1h indole derivative | |
dc.subject | 5 bromo 3 [3 [4 [3 (5 fluoro 1h 3 indolyl)propyl]piperazinyl]propyl] 1h indol | |
dc.subject | 5 bromo 3 [3 [4 [3 (5 methoxy 1h 3 indolyl)propyl]piperazinyl]propyl] 1h indol | |
dc.subject | 5 fluoro 3 [3 [4 [3 (5 methoxy 1h 3 indolyl)propyl]piperazinyl]propyl] 1h indol | |
dc.subject | citalopram | |
dc.subject | indole derivative | |
dc.subject | serotonin 1A receptor | |
dc.subject | serotonin transporter | |
dc.subject | unclassified drug | |
dc.subject | animal tissue | |
dc.subject | article | |
dc.subject | binding affinity | |
dc.subject | controlled study | |
dc.subject | drug structure | |
dc.subject | drug synthesis | |
dc.subject | human | |
dc.subject | human cell | |
dc.subject | in vitro study | |
dc.subject | molecular docking | |
dc.subject | nonhuman | |
dc.subject | rat | |
dc.subject | 5-Hydroxytryptamine 1A receptor | |
dc.subject | Bivalent ligands | |
dc.subject | Docking | |
dc.subject | Piperazinylpropylindole derivatives | |
dc.subject | Serotonin transporter | |
dc.subject | Dose-Response Relationship, Drug | |
dc.subject | Humans | |
dc.subject | Indoles | |
dc.subject | Models, Molecular | |
dc.subject | Molecular Docking Simulation | |
dc.subject | Molecular Structure | |
dc.subject | Piperazines | |
dc.subject | Receptor, Serotonin, 5-HT1A | |
dc.subject | Serotonin Plasma Membrane Transport Proteins | |
dc.subject | Structure-Activity Relationship | |
dc.title | Synthesis, docking and pharmacological evaluation of novel homo- and hetero-bis 3-piperazinylpropylindole derivatives at SERT and 5-HT1A receptor | |
dc.type | Article |